China's CanSino Pushing for Early Authorization for COVID-19 Vaccine
China's CanSino Biologics is currently lobbying regulators abroad to grant its vaccine candidate the equivalent of the U.S. Food and Drug Administration's emergency use authorization (EUA). The company's Senior Vice President for International Business, Pierre Morgon, revealed this in a story published Friday in The Wall Street Journal.
Morgon said that his company is talking to regulators in numerous countries, declining to name any save for Pakistan. He also said that discussions are occurring with unnamed nations in Latin America and elsewhere.
Image source: Getty Images.
Source Fool.com
